CYP19A1 rs7176005: Understanding Aromatase Gene Variation

What each genotype means

What is rs7176005?

The rs7176005 variant is a specific change in the DNA sequence of the CYP19A1 gene, located on chromosome 15. In genetics, a single nucleotide polymorphism (SNP) like rs7176005 represents a variation at a single position in the DNA building blocks. This particular SNP is often studied alongside other variants in the same gene, such as rs6493497, because they are frequently inherited together in a pattern known as linkage disequilibrium. Because these variants are physically close on the chromosome, they are often passed down as a block, which can complicate efforts to determine which specific change is responsible for a biological effect. Researchers analyze these patterns to understand how subtle differences in our genetic code might influence the body's internal chemistry.

The Role of the CYP19A1 Gene

The CYP19A1 gene provides the essential instructions for the body to produce an enzyme called aromatase. Aromatase is a critical component of the cytochrome P450 superfamily and acts as an estrogen synthase. Its primary function is to convert androgens—male-type hormones—into estrogens, which are vital for various reproductive and physiological processes. In postmenopausal women, the ovaries no longer produce significant amounts of estrogen, making peripheral tissues the primary site for estrogen synthesis via aromatase. Because of this central role in hormone production, the activity of the aromatase enzyme is a major target for medical interventions, particularly in the treatment of hormone-sensitive conditions like certain types of breast cancer, where reducing estrogen levels can help slow or stop tumor growth.

Research and Clinical Associations

Scientific research has investigated whether rs7176005 influences the expression or activity of the aromatase enzyme. Some studies suggest that this variant, often in combination with others, may be associated with variations in circulating estrogen levels or differences in how patients respond to aromatase inhibitor (AI) therapies. The evidence for these associations is considered moderate, as findings have been mixed across different study populations and clinical settings. While some research indicates a potential link to treatment outcomes or side-effect profiles in breast cancer patients, other studies have not consistently replicated these results. Because of this variability, the clinical utility of using rs7176005 as a predictive biomarker for drug response remains an active area of investigation rather than a standard clinical practice.

Population Frequency and Interpretation

The frequency of the rs7176005 variant is known to vary significantly across different ancestral populations. Genetic studies often observe that the distribution of alleles—the specific versions of the SNP—differs between groups of European, Asian, and African descent. This variation is common in human genetics, as evolutionary history and geographic isolation have shaped the genetic landscape of different populations. When interpreting data regarding this SNP, it is important to recognize that a result observed in one ethnic group may not necessarily apply to another. Because the frequency and the associated biological impact can be ancestry-specific, researchers emphasize the need for diverse study cohorts to fully understand the implications of this variant on a global scale.

What This Means for You

If you have information about your rs7176005 genotype, it is important to understand that this is a research-level finding rather than a diagnostic tool. Genetic variants in CYP19A1 are just one of many factors that can influence hormone levels and medication response. Other variables, including age, overall health, lifestyle, and the presence of other genetic markers, play significant roles in how your body processes hormones and medications. You should never use this information to make decisions about your medical care or to alter your prescribed treatments. If you are concerned about how your genetics might affect your response to a specific medication, such as an aromatase inhibitor, please discuss this with your clinician or pharmacist. They can provide context based on your full medical history and current clinical guidelines.

Frequently asked questions

Sources & further reading

Related variants in CYP19A1